Navigation Links
University of Wisconsin Carbone Cancer Center to Acquire ViewRay Radiation Therapy System

CLEVELAND, March 9, 2011 /PRNewswire/ -- The University of Wisconsin Carbone Cancer Center (UWCCC) in Madison, Wisconsin, will soon become one of the first oncology research centers to acquire a radiotherapy system from ViewRay™, Inc., a privately held medical device company. ViewRay's new research radiation therapy system features a unique combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI). The ViewRay system is being designed to provide continuous soft-tissue MRI during treatment so that clinicians can see precisely where the radiation is being delivered.

Radiation therapy is critical in the fight against cancer, and nearly two-thirds of all cancer patients receive radiation therapy during their illness. However, natural organ motion can hinder the precision of radiation delivery to the tumor. "Patients breathe, swallow, and digest with movement of internal organs during treatment," said Paul M. Harari, MD, professor and chair of the UW Department of Human Oncology. "We plan to use the system to observe and address this problem in a new way with the use of MR imaging. Our researchers are particularly interested in studying possible applications in the treatment of thoracic, abdominal, and pelvic malignancies, where precise radiation targeting must account for organ motion."

The UWCCC is known for conducting some of the most innovative research in the field. A number of original treatment technologies have been developed at UW, particularly in the area of image-guided radiotherapy using pretreatment CT. "We have great respect for the work of UW's researchers and clinicians, and we've enjoyed a longstanding connection to the Carbone Cancer Center," said ViewRay President and CEO Gregory M. Ayers, MD, PhD. "Now the UWCCC team will lead the radiation oncology community in exploring a new way of monitoring treatments and adapting to changes in a patient's anatomy." The ViewRay system is designed to enable clinicians to plan and deliver precision radiotherapy and radiosurgery to treat lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated.

ViewRay holds the exclusive worldwide license for its combination of MRI and radiotherapy technologies. Now in the late stages of development, the ViewRay system is currently available only as a non–human use research system. The company is working to secure clearance from the U.S. FDA for commercial distribution of the system for clinical use.

About ViewRay

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay system is being designed to provide continuous soft-tissue imaging during treatment so that clinicians will be able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. The system is intended to give clinicians a fresh approach to observing, assessing, and personalizing a patient's treatment. For more information, visit

ViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Radiotherapy Guidance Project.

About the UW Carbone Cancer Center

The University of Wisconsin Carbone Cancer Center (UWCCC) is recognized throughout the nation as one of the leading innovators in cancer research, quality patient care, teaching, and active community involvement. An integral part of the UW School of Medicine and Public Health, the UWCCC unites more than 250 physicians and scientists who work together in translating discoveries from research laboratories into new treatments that benefit cancer patients. It is the only comprehensive cancer center, as designated by the National Cancer Institute, in the state of Wisconsin. For more information, visit

ViewRay is a trademark of ViewRay, Inc.

SOURCE ViewRay, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The University of Kansas Cancer Center and U.S. Oncology-Affiliated Kansas City Cancer Center to Merge Operations to Promote Patient Care and Research
2. Mira Dx Licenses Triple Negative Breast Cancer Risk Variant from Yale University
3. University Radiology Group Works With MedInformatix to Meet Stage 1 Meaningful Use Qualifications
4. Zell Lurie Institute Awards $106,300 to University of Michigan Students Through the Michigan Business Challenge and Dare to Dream Startup Grant Program
5. University of North Carolina Hospitals Selects Carefx Business Intelligence Dashboards To Drive Performance Improvement
6. University Hospitals Selects Allscripts Electronic Health Record for 1,400 Physicians and Expands Sunrise™ Enterprise Acute Care EHR in Eight Hospitals
7. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
8. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
9. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
10. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
11. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
Post Your Comments:
(Date:11/30/2015)... and BOCA RATON, Fla. ... for the Commercialization of Public Research (the Institute) ... with KynderMed , a medical device start-up company ... supports new company creation based on publicly-funded research, and ... Florida -based universities and research institutions. ...
(Date:11/30/2015)...  Kevin Smith has been appointed Chief Commercial ... in wireless monitoring of vital signs.  As CCO ... Mr. Smith will be responsible for the development ... will also directly oversee partnering with US hospitals ... SensiumVitals, the first early warning detection device to ...
(Date:11/30/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ), a ... drug delivery systems, announced today it has signed definitive ... Incubator of Technologies Co., Ltd. ("HTIT") for exclusive rights ... China , Hong Kong ... were signed at the Israel Knesset (Parliament). ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... TCS Healthcare Technologies (TCS), a leading ... arenas, is pleased to announce that VIP Care Services, a Caprock Health Group ... ACUITY Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY ...
(Date:12/1/2015)... Park, CA (PRWEB) , ... December 01, 2015 , ... ... (XTC) has selected 10 semi-finalists to head to Las Vegas for CES 2016, the ... judges including CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: ... with full control over customization, the possibilities are truly endless, all with a click ... overlay depth position, vertical flip, horizontal flip, depth of field and more, all within ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. ... a Modern Man for 2015. , Angeleno Magazine is a division of ... Established in 1994, Modern Luxury includes more than 50 magazine titles across 15 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes ... and support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact ...
Breaking Medicine News(10 mins):